Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderately to Severely Active Crohn Disease”

Showing 20 of 0 results

Not applicableStudy completedNCT05394805
What this trial is testing

Subcutaneous HUMIRA (Adalimumab) Injection to Assess Adverse Events and Change in Disease Activity In Adult Participants With Moderate to Severe Active Crohn's Disease (CD)

Who this might be right for
Crohn's Disease
AbbVie 156
Not applicableStudy completedNCT00524537
What this trial is testing

A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)

Who this might be right for
Crohn's Disease
AbbVie (prior sponsor, Abbott) 5,025
Large-scale testing (Phase 3)Study completedNCT02394028
What this trial is testing

Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Hoffmann-La Roche 1,035
Not applicableLooking for participantsNCT06023030
What this trial is testing

An Observational Study to Assess Change in Disease Activity and Adverse Events in Adolescent and Adult Participants With Moderate to Severe Active Crohn's Disease (CD) in Japan

Who this might be right for
Crohn's Disease
AbbVie 240
Large-scale testing (Phase 3)WithdrawnNCT03905109
What this trial is testing

Phase 2b/3 Study of ABX464 in Moderate to Severe Active Crohn's Disease Patients

Who this might be right for
Crohn Disease
Abivax S.A.
Testing effectiveness (Phase 2)Study completedNCT00055367
What this trial is testing

Safety, Tolerability and Effectiveness of Natalizumab in Adolescents With Active Crohn's Disease

Who this might be right for
Crohn's Disease
Biogen 30
Large-scale testing (Phase 3)Active Not RecruitingNCT03466411
What this trial is testing

The Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Janssen Research & Development, LLC 1,409
Testing effectiveness (Phase 2)Study completedNCT00102921
What this trial is testing

Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease

Who this might be right for
Crohn Disease
Amgen 70
Large-scale testing (Phase 3)Study completedNCT04397263
What this trial is testing

Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohns Disease
Janssen Pharmaceutical K.K. 38
Large-scale testing (Phase 3)Ended earlyNCT05470985
What this trial is testing

Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Therapy

Who this might be right for
Crohn Disease
Bristol-Myers Squibb 5
Large-scale testing (Phase 3)Study completedNCT02425111
What this trial is testing

Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease

Who this might be right for
Crohn's Disease
Takeda 101
Testing effectiveness (Phase 2)Study completedNCT00042055
What this trial is testing

CP-461 for the Treatment of Crohn's Disease

Who this might be right for
Crohn's Disease
Astellas Pharma Inc 30
Testing effectiveness (Phase 2)Study completedNCT03677648
What this trial is testing

A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease

Who this might be right for
Crohn's Disease
Reistone Biopharma Company Limited 112
Large-scale testing (Phase 3)Looking for participantsNCT06819891
What this trial is testing

Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Moderately to Severely Active Crohns Disease
Hoffmann-La Roche 425
Testing effectiveness (Phase 2)Looking for participantsNCT07697456
What this trial is testing

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Who this might be right for
Crohn's DiseaseUlcerative Colitis
AbbVie 2,000
Large-scale testing (Phase 3)Ended earlyNCT03961815
What this trial is testing

Open-label Extension Study of Brazikumab in Crohn's Disease

Who this might be right for
Crohn's DiseaseIBD
AstraZeneca 18
Large-scale testing (Phase 3)Ended earlyNCT01536418
What this trial is testing

An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease

Who this might be right for
Crohn's Disease
GlaxoSmithKline 255
Large-scale testing (Phase 3)Looking for participantsNCT07184931
What this trial is testing

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Sanofi 980
Large-scale testing (Phase 3)Study completedNCT00552058
What this trial is testing

Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease

Who this might be right for
Crohn Disease
UCB Pharma 439
Post-approval studies (Phase 4)Looking for participantsNCT07663526
What this trial is testing

Treatment of Chinese Adult Subjects With Moderate to Severe Crohn's Disease With Tabellvi®

Who this might be right for
Crohn's Disease
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 50
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation